バイオテクノロジー市場調査レポート：技術（セルベースアッセイ、クロマトグラフィー、DNAシーケンシング）、用途、地域別-世界予測2023-2030年

バイオテクノロジーの世界市場規模は、2022年に1兆231億5000万米ドルと推定され、2023年には1兆1953億米ドルに達し、2030年には3兆5,833億6,000万米ドルに達する見込みで、CAGR16.96%の成長が予想されています。

ロシア・ウクライナ紛争の累積的影響

ロシア・ウクライナ紛争による政治的・経済的な不確実性を考慮し、継続的に監視し、レポートを更新しています。特に東欧、欧州連合、東・中央アジア、米国など世界的に悪影響が予測されます。この紛争は、人々の生命と暮らしに深刻な影響を与え、貿易力学に広範囲な混乱をもたらすものです。東欧で進行中の戦争と不確実性の潜在的影響は、ウクライナに悪影響を及ぼし、ロシアに長期的に厳しい影響を及ぼすと予想されます。本レポートでは、需要と供給のバランス、価格変動への圧力、輸出入と取引への影響、紛争とその世界の対応に関する最新情報を考慮した世界のバイオテクノロジー市場への短期的な提言について明らかにしています。

高インフレの累積的影響

世界の新興経済諸国における高インフレは、過去2年間における全体的な物価の高騰をもたらしました。累積的に浸食される全体的な購買力は、新興経済諸国に大きな影響を与えると予想され、多くの点で有用であると考えられています。本レポートでは、高インフレが世界経済の長期的パフォーマンスに与える影響を明らかにし、財政政策による需要/供給、キャッシュフロー、為替への短期的影響の測定と軽減について詳しく解説しています。世界のバイオテクノロジー市場のレポートは、コストプッシュ型インフレと需要プル型インフレによる関連影響を考慮した高インフレ予想を提供しています。

市場の統計

本レポートでは、米ドル、ユーロ、日本円、英ポンド、豪ドル、カナダドル、スイスフランの主要7通貨における市場規模と予測を提供しており、複数通貨対応により、組織のリーダーがより良い意思決定を行えるよう支援しています。本レポートでは、2018年と2021年を過去年、2022年を基本年、2023年を推定年、2024年から2030年までの年を予測期間とみなしています。

市場セグメンテーションとカバレッジ

世界のバイオテクノロジー市場に関するレポートでは、潜在的な市場を定義し、業界全体で異なるニーズを特定するために、顧客に関する主要な属性を特定しています。潜在的な顧客グループの経済や地域を理解することは、より良い戦略的意思決定のためのビジネス洞察力を得るのに役立ちます。本レポートでは、様々な業界を網羅した市場調査から、各業界のプレーヤーがどのような戦略を持っているのか、その隠された真実を明らかにし、企業がターゲットとする顧客を決定するのに役立ちます。本レポートは、包括的な産業範囲と結合したサブ市場の複合ビューを提供し、市場計画のための正しいカバー戦略を立てるために、規範と規制、文化などの要因を考慮する正しい方法を提供します。この調査レポートは、世界のバイオテクノロジー市場を分類し、以下の各小市場における収益と動向を予測しています。

技術に基づき、市場はセルベースアッセイ、クロマトグラフィー、DNAシーケンス、発酵、ナノバイオテクノロジー、PCR技術、組織工学と再生にまたがって調査されます。

用途別では、バイオインフォマティクス、食品・農業、健康、工業処理、天然資源・環境について調査しています。

地域別では、南北アメリカ、アジア太平洋、欧州、中東・アフリカで調査しています。南北アメリカはさらに、アルゼンチン、ブラジル、カナダ、メキシコ、米国の各地域で調査しています。米国はさらに、カリフォルニア、フロリダ、イリノイ、ニューヨーク、オハイオ、ペンシルバニア、テキサスにわたって調査されています。アジア太平洋地域は、オーストラリア、中国、インド、インドネシア、日本、マレーシア、フィリピン、シンガポール、韓国、台湾、タイ、ベトナムでさらに調査しています。欧州・中東・アフリカは、デンマーク、エジプト、フィンランド、フランス、ドイツ、イスラエル、イタリア、オランダ、ナイジェリア、ノルウェー、ポーランド、カタール、ロシア、サウジアラビア、南アフリカ、スペイン、スウェーデン、スイス、トルコ、アラブ首長国連邦、英国についてさらに詳しく調査しています。

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックス：世界のバイオテクノロジー市場におけるベンダーを評価・分類したものです。事業戦略（事業成長性、業界網羅性、財務的安定性、チャネルサポート）と製品満足度（コストパフォーマンス、使いやすさ、製品機能、顧客サポート）に基づき、4つの象限（F：Forefront, P：Pathfinder, N：Niche, V：Vital）に分類しています。世界のバイオテクノロジー市場のFPNVポジショニングックス表現/視覚化は、企業がより良い意思決定を行い、競合情勢を理解する上でさらなる助けとなるものです。

市場シェア分析

市場シェア分析では、市場全体への貢献度を考慮したベンダーの分析を行い、同分野の他のベンダーと比較した市場全体への収益発生のアイデアを提供します。これにより、収益創出や顧客基盤の面で、他と比較したベンダーのパフォーマンスに関する洞察を提供します。世界のバイオテクノロジー市場のシェア分析では、基準年のベンダーの規模や競争力を知ることができます。結果は蓄積、断片化、優位性、合併特性の観点から市場の特性を明らかにします。

本レポートは、以下のポイントに関する洞察を提供しています。

1-市場の浸透度：主要企業が提供する市場に関する包括的な情報を提供します。

2-市場の開拓：有利な新興市場に関する詳細な情報を提供し、市場の成熟したセグメントにおける浸透度を分析します。

3-市場の多様化：新製品の上市、未開拓の地域、最近の開発、投資に関する詳細情報を提供

4-市場の動向。COVID-19の累積的な影響、ロシア・ウクライナ紛争、高インフレについて包括的に理解することができます。

5-競合の評価と情報：主要企業の市場シェア、戦略、製品、認証、規制当局の承認、特許状況、製造能力に関する徹底的な評価を提供します。

6-製品開発およびイノベーション：将来技術、R&D活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような質問に回答しています。

1-世界のバイオテクノロジー市場の市場規模および予測は？

2-予測期間中に世界のバイオテクノロジー市場を形成するCOVID-19の阻害要因および影響は何か？

3-バイオテクノロジーの世界市場において、予測期間中に投資すべき製品/セグメント/アプリケーション/領域は何か？

4-世界のバイオテクノロジー市場における競争戦略の窓は何か？

5-世界のバイオテクノロジー市場における技術動向と規制の枠組みは？

6-バイオテクノロジーの世界市場における主要ベンダーの市場シェアは？

7-世界のバイオテクノロジー市場への参入に適していると考えられるモードや戦略的な動きは？

目次

第1章 序文

• 調査の目的
• 市場セグメンテーションとカバレッジ
• 調査対象年
• 通貨と価格
• 言語
• 制限事項
• 前提条件
• 利害関係者

第2章 調査手法

• 定義：調査目的
• 決定：調査デザイン
• 準備：調査票の作成
• 収集：データソース
• 分析：データ解釈
• 定式化：データの検証
• 出版：調査レポート作成
• 繰り返し：レポートの更新

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場インサイト

• 市場力学
  • 促進要因
    • 栄養補助食品と園芸品への関心の高まり
    • 持続的な健康状態の発生率の増加
    • 疾病の早期発見と相まって、個別化された医薬品に対する需要の急増
  • 抑制要因
    • 遺伝子データに関するリスク
  • ビジネスチャンス
    • 革新的な技術の出現
    • 農作物に対する需要の高まり
  • 課題
    • バイオテクノロジー別環境への悪影響
• COVID-19の累積的な影響
• ロシア・ウクライナ紛争の累積的影響
• 高インフレの累積的影響
• ポーターのファイブフォース分析
  • 新規参入業者の脅威
  • 代替品の脅威
  • 代替品の脅威
  • 代替品の脅威
  • 産業競争力
• バリューチェーンとクリティカルパス分析
• 規制の枠組み
• 顧客のカスタマイズ

第6章 バイオテクノロジー市場：技術別

• セルベースアッセイ
• クロマトグラフィー
• DNAシーケンシング
• 発酵
• ナノバイオテクノロジー
• PCR技術
• 組織工学と再生

第7章 バイオテクノロジー市場：アプリケーション別

• バイオインフォマティクス
• 食品・農業
• 健康分野
• 工業処理
• 資源・環境

第8章 南北アメリカのバイオテクノロジー市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第9章 アジア太平洋地域のバイオテクノロジー市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第10章 欧州・中東・アフリカバイオテクノロジー市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第11章 競合情勢

• FPNVポジショニングマトリクス
  • クワドラント
  • 事業戦略
  • 製品満足度
• キープレイヤー別市場ランキング分析
• 市場シェア分析（キープレイヤー別
• 製品ポートフォリオ分析,キープレイヤー別
• 競合シナリオ
  • 合併・買収
  • 契約、コラボレーション、パートナーシップ
  • 新製品発売と機能強化
  • 投資、資金調達
  • 受賞・表彰・拡大

第12章 企業ユーザビリティプロファイル

• Abbott Laboratories Ltd.
• Agilent Technologies, Inc.
• Amgen Inc.
• Bio-Rad Laboratories, Inc.
• bioMerieux SA
• Danaher Corporation
• F. Hoffmann-La Roche AG
• General Electric Company
• Gilead Sciences, Inc.
• Lonza Group
• Novartis AG
• Novo Nordisk A/S
• PerkinElmer, Inc.
• QIAGEN
• Samudra Biopharma Pvt. Ltd
• Thermo Fisher Scientific Inc

第13章 付録

• ディスカッションガイド
• ライセンスと価格について

LIST OF FIGURES

• FIGURE 1. GLOBAL BIOTECHNOLOGY MARKET: RESEARCH PROCESS
• FIGURE 2. GLOBAL BIOTECHNOLOGY MARKET SIZE, 2022 VS 2030
• FIGURE 3. GLOBAL BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
• FIGURE 4. GLOBAL BIOTECHNOLOGY MARKET SIZE, BY REGION, 2022 VS 2030 (%)
• FIGURE 5. GLOBAL BIOTECHNOLOGY MARKET SIZE, BY REGION, 2022 VS 2023 VS 2030 (USD BILLION)
• FIGURE 6. GLOBAL BIOTECHNOLOGY MARKET COMPETITIVE STRATEGIC WINDOW, BY REGION, 2030
• FIGURE 7. GLOBAL BIOTECHNOLOGY MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
• FIGURE 8. GLOBAL BIOTECHNOLOGY MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD BILLION)
• FIGURE 9. GLOBAL BIOTECHNOLOGY MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2030
• FIGURE 10. GLOBAL BIOTECHNOLOGY MARKET DYNAMICS
• FIGURE 11. GLOBAL BIOTECHNOLOGY MARKET PORTER'S FIVE FORCES ANALYSIS
• FIGURE 12. GLOBAL BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2022 VS 2030 (%)
• FIGURE 13. GLOBAL BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2022 VS 2023 VS 2030 (USD BILLION)
• FIGURE 14. GLOBAL BIOTECHNOLOGY MARKET COMPETITIVE STRATEGIC WINDOW, BY TECHNOLOGY, 2030
• FIGURE 15. GLOBAL BIOTECHNOLOGY MARKET SIZE, BY CELL-BASED ASSAYS, 2018-2030 (USD BILLION)
• FIGURE 16. GLOBAL BIOTECHNOLOGY MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD BILLION)
• FIGURE 17. GLOBAL BIOTECHNOLOGY MARKET SIZE, BY DNA SEQUENCING, 2018-2030 (USD BILLION)
• FIGURE 18. GLOBAL BIOTECHNOLOGY MARKET SIZE, BY FERMENTATION, 2018-2030 (USD BILLION)
• FIGURE 19. GLOBAL BIOTECHNOLOGY MARKET SIZE, BY NANOBIOTECHNOLOGY, 2018-2030 (USD BILLION)
• FIGURE 20. GLOBAL BIOTECHNOLOGY MARKET SIZE, BY PCR TECHNOLOGY, 2018-2030 (USD BILLION)
• FIGURE 21. GLOBAL BIOTECHNOLOGY MARKET SIZE, BY TISSUE ENGINEERING & REGENERATION, 2018-2030 (USD BILLION)
• FIGURE 22. GLOBAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2022 VS 2030 (%)
• FIGURE 23. GLOBAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2022 VS 2023 VS 2030 (USD BILLION)
• FIGURE 24. GLOBAL BIOTECHNOLOGY MARKET COMPETITIVE STRATEGIC WINDOW, BY APPLICATION, 2030
• FIGURE 25. GLOBAL BIOTECHNOLOGY MARKET SIZE, BY BIOINFORMATICS, 2018-2030 (USD BILLION)
• FIGURE 26. GLOBAL BIOTECHNOLOGY MARKET SIZE, BY FOOD & AGRICULTURE, 2018-2030 (USD BILLION)
• FIGURE 27. GLOBAL BIOTECHNOLOGY MARKET SIZE, BY HEALTH, 2018-2030 (USD BILLION)
• FIGURE 28. GLOBAL BIOTECHNOLOGY MARKET SIZE, BY INDUSTRIAL PROCESSING, 2018-2030 (USD BILLION)
• FIGURE 29. GLOBAL BIOTECHNOLOGY MARKET SIZE, BY NATURAL RESOURCES & ENVIRONMENT, 2018-2030 (USD BILLION)
• FIGURE 30. AMERICAS BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
• FIGURE 31. AMERICAS BIOTECHNOLOGY MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
• FIGURE 32. AMERICAS BIOTECHNOLOGY MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD BILLION)
• FIGURE 33. AMERICAS BIOTECHNOLOGY MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2030
• FIGURE 34. ARGENTINA BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
• FIGURE 35. BRAZIL BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
• FIGURE 36. CANADA BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
• FIGURE 37. MEXICO BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
• FIGURE 38. UNITED STATES BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
• FIGURE 39. UNITED STATES BIOTECHNOLOGY MARKET SIZE, BY STATE, 2022 VS 2030 (%)
• FIGURE 40. UNITED STATES BIOTECHNOLOGY MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD BILLION)
• FIGURE 41. UNITED STATES BIOTECHNOLOGY MARKET COMPETITIVE STRATEGIC WINDOW, BY STATE, 2030
• FIGURE 42. ASIA-PACIFIC BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
• FIGURE 43. ASIA-PACIFIC BIOTECHNOLOGY MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
• FIGURE 44. ASIA-PACIFIC BIOTECHNOLOGY MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD BILLION)
• FIGURE 45. ASIA-PACIFIC BIOTECHNOLOGY MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2030
• FIGURE 46. AUSTRALIA BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
• FIGURE 47. CHINA BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
• FIGURE 48. INDIA BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
• FIGURE 49. INDONESIA BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
• FIGURE 50. JAPAN BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
• FIGURE 51. MALAYSIA BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
• FIGURE 52. PHILIPPINES BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
• FIGURE 53. SINGAPORE BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
• FIGURE 54. SOUTH KOREA BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
• FIGURE 55. TAIWAN BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
• FIGURE 56. THAILAND BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
• FIGURE 57. VIETNAM BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
• FIGURE 58. EUROPE, MIDDLE EAST & AFRICA BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
• FIGURE 59. EUROPE, MIDDLE EAST & AFRICA BIOTECHNOLOGY MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
• FIGURE 60. EUROPE, MIDDLE EAST & AFRICA BIOTECHNOLOGY MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD BILLION)
• FIGURE 61. EUROPE, MIDDLE EAST & AFRICA BIOTECHNOLOGY MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2030
• FIGURE 62. DENMARK BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
• FIGURE 63. EGYPT BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
• FIGURE 64. FINLAND BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
• FIGURE 65. FRANCE BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
• FIGURE 66. GERMANY BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
• FIGURE 67. ISRAEL BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
• FIGURE 68. ITALY BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
• FIGURE 69. NETHERLANDS BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
• FIGURE 70. NIGERIA BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
• FIGURE 71. NORWAY BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
• FIGURE 72. POLAND BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
• FIGURE 73. QATAR BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
• FIGURE 74. RUSSIA BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
• FIGURE 75. SAUDI ARABIA BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
• FIGURE 76. SOUTH AFRICA BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
• FIGURE 77. SPAIN BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
• FIGURE 78. SWEDEN BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
• FIGURE 79. SWITZERLAND BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
• FIGURE 80. TURKEY BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
• FIGURE 81. UNITED ARAB EMIRATES BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
• FIGURE 82. UNITED KINGDOM BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
• FIGURE 83. GLOBAL BIOTECHNOLOGY MARKET: FPNV POSITIONING MATRIX, 2022
• FIGURE 84. GLOBAL BIOTECHNOLOGY MARKET SHARE, BY KEY PLAYER, 2022
• FIGURE 85. GLOBAL BIOTECHNOLOGY MARKET COMPETITIVE SCENARIO, BY KEY TYPE, 2022

LIST OF TABLES

• TABLE 1. GLOBAL BIOTECHNOLOGY MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
• TABLE 3. GLOBAL BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
• TABLE 4. GLOBAL BIOTECHNOLOGY MARKET SIZE, BY REGION, 2018-2030 (USD BILLION)
• TABLE 5. GLOBAL BIOTECHNOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD BILLION)
• TABLE 6. GLOBAL BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD BILLION)
• TABLE 7. GLOBAL BIOTECHNOLOGY MARKET SIZE, BY CELL-BASED ASSAYS, 2018-2030 (USD BILLION)
• TABLE 8. GLOBAL BIOTECHNOLOGY MARKET SIZE, BY CELL-BASED ASSAYS, BY REGION, 2018-2030 (USD BILLION)
• TABLE 9. GLOBAL BIOTECHNOLOGY MARKET SIZE, BY CELL-BASED ASSAYS, BY REGION, 2018-2030 (USD BILLION)
• TABLE 10. GLOBAL BIOTECHNOLOGY MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD BILLION)
• TABLE 11. GLOBAL BIOTECHNOLOGY MARKET SIZE, BY CHROMATOGRAPHY, BY REGION, 2018-2030 (USD BILLION)
• TABLE 12. GLOBAL BIOTECHNOLOGY MARKET SIZE, BY CHROMATOGRAPHY, BY REGION, 2018-2030 (USD BILLION)
• TABLE 13. GLOBAL BIOTECHNOLOGY MARKET SIZE, BY DNA SEQUENCING, 2018-2030 (USD BILLION)
• TABLE 14. GLOBAL BIOTECHNOLOGY MARKET SIZE, BY DNA SEQUENCING, BY REGION, 2018-2030 (USD BILLION)
• TABLE 15. GLOBAL BIOTECHNOLOGY MARKET SIZE, BY DNA SEQUENCING, BY REGION, 2018-2030 (USD BILLION)
• TABLE 16. GLOBAL BIOTECHNOLOGY MARKET SIZE, BY FERMENTATION, 2018-2030 (USD BILLION)
• TABLE 17. GLOBAL BIOTECHNOLOGY MARKET SIZE, BY FERMENTATION, BY REGION, 2018-2030 (USD BILLION)
• TABLE 18. GLOBAL BIOTECHNOLOGY MARKET SIZE, BY FERMENTATION, BY REGION, 2018-2030 (USD BILLION)
• TABLE 19. GLOBAL BIOTECHNOLOGY MARKET SIZE, BY NANOBIOTECHNOLOGY, 2018-2030 (USD BILLION)
• TABLE 20. GLOBAL BIOTECHNOLOGY MARKET SIZE, BY NANOBIOTECHNOLOGY, BY REGION, 2018-2030 (USD BILLION)
• TABLE 21. GLOBAL BIOTECHNOLOGY MARKET SIZE, BY NANOBIOTECHNOLOGY, BY REGION, 2018-2030 (USD BILLION)
• TABLE 22. GLOBAL BIOTECHNOLOGY MARKET SIZE, BY PCR TECHNOLOGY, 2018-2030 (USD BILLION)
• TABLE 23. GLOBAL BIOTECHNOLOGY MARKET SIZE, BY PCR TECHNOLOGY, BY REGION, 2018-2030 (USD BILLION)
• TABLE 24. GLOBAL BIOTECHNOLOGY MARKET SIZE, BY PCR TECHNOLOGY, BY REGION, 2018-2030 (USD BILLION)
• TABLE 25. GLOBAL BIOTECHNOLOGY MARKET SIZE, BY TISSUE ENGINEERING & REGENERATION, 2018-2030 (USD BILLION)
• TABLE 26. GLOBAL BIOTECHNOLOGY MARKET SIZE, BY TISSUE ENGINEERING & REGENERATION, BY REGION, 2018-2030 (USD BILLION)
• TABLE 27. GLOBAL BIOTECHNOLOGY MARKET SIZE, BY TISSUE ENGINEERING & REGENERATION, BY REGION, 2018-2030 (USD BILLION)
• TABLE 28. GLOBAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
• TABLE 29. GLOBAL BIOTECHNOLOGY MARKET SIZE, BY BIOINFORMATICS, 2018-2030 (USD BILLION)
• TABLE 30. GLOBAL BIOTECHNOLOGY MARKET SIZE, BY BIOINFORMATICS, BY REGION, 2018-2030 (USD BILLION)
• TABLE 31. GLOBAL BIOTECHNOLOGY MARKET SIZE, BY BIOINFORMATICS, BY REGION, 2018-2030 (USD BILLION)
• TABLE 32. GLOBAL BIOTECHNOLOGY MARKET SIZE, BY FOOD & AGRICULTURE, 2018-2030 (USD BILLION)
• TABLE 33. GLOBAL BIOTECHNOLOGY MARKET SIZE, BY FOOD & AGRICULTURE, BY REGION, 2018-2030 (USD BILLION)
• TABLE 34. GLOBAL BIOTECHNOLOGY MARKET SIZE, BY FOOD & AGRICULTURE, BY REGION, 2018-2030 (USD BILLION)
• TABLE 35. GLOBAL BIOTECHNOLOGY MARKET SIZE, BY HEALTH, 2018-2030 (USD BILLION)
• TABLE 36. GLOBAL BIOTECHNOLOGY MARKET SIZE, BY HEALTH, BY REGION, 2018-2030 (USD BILLION)
• TABLE 37. GLOBAL BIOTECHNOLOGY MARKET SIZE, BY HEALTH, BY REGION, 2018-2030 (USD BILLION)
• TABLE 38. GLOBAL BIOTECHNOLOGY MARKET SIZE, BY INDUSTRIAL PROCESSING, 2018-2030 (USD BILLION)
• TABLE 39. GLOBAL BIOTECHNOLOGY MARKET SIZE, BY INDUSTRIAL PROCESSING, BY REGION, 2018-2030 (USD BILLION)
• TABLE 40. GLOBAL BIOTECHNOLOGY MARKET SIZE, BY INDUSTRIAL PROCESSING, BY REGION, 2018-2030 (USD BILLION)
• TABLE 41. GLOBAL BIOTECHNOLOGY MARKET SIZE, BY NATURAL RESOURCES & ENVIRONMENT, 2018-2030 (USD BILLION)
• TABLE 42. GLOBAL BIOTECHNOLOGY MARKET SIZE, BY NATURAL RESOURCES & ENVIRONMENT, BY REGION, 2018-2030 (USD BILLION)
• TABLE 43. GLOBAL BIOTECHNOLOGY MARKET SIZE, BY NATURAL RESOURCES & ENVIRONMENT, BY REGION, 2018-2030 (USD BILLION)
• TABLE 44. AMERICAS BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
• TABLE 45. AMERICAS BIOTECHNOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD BILLION)
• TABLE 46. AMERICAS BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD BILLION)
• TABLE 47. AMERICAS BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
• TABLE 48. ARGENTINA BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
• TABLE 49. ARGENTINA BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD BILLION)
• TABLE 50. ARGENTINA BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
• TABLE 51. BRAZIL BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
• TABLE 52. BRAZIL BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD BILLION)
• TABLE 53. BRAZIL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
• TABLE 54. CANADA BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
• TABLE 55. CANADA BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD BILLION)
• TABLE 56. CANADA BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
• TABLE 57. MEXICO BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
• TABLE 58. MEXICO BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD BILLION)
• TABLE 59. MEXICO BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
• TABLE 60. UNITED STATES BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
• TABLE 61. UNITED STATES BIOTECHNOLOGY MARKET SIZE, BY STATE, 2018-2030 (USD BILLION)
• TABLE 62. UNITED STATES BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD BILLION)
• TABLE 63. UNITED STATES BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
• TABLE 64. ASIA-PACIFIC BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
• TABLE 65. ASIA-PACIFIC BIOTECHNOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD BILLION)
• TABLE 66. ASIA-PACIFIC BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD BILLION)
• TABLE 67. ASIA-PACIFIC BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
• TABLE 68. AUSTRALIA BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
• TABLE 69. AUSTRALIA BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD BILLION)
• TABLE 70. AUSTRALIA BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
• TABLE 71. CHINA BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
• TABLE 72. CHINA BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD BILLION)
• TABLE 73. CHINA BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
• TABLE 74. INDIA BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
• TABLE 75. INDIA BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD BILLION)
• TABLE 76. INDIA BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
• TABLE 77. INDONESIA BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
• TABLE 78. INDONESIA BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD BILLION)
• TABLE 79. INDONESIA BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
• TABLE 80. JAPAN BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
• TABLE 81. JAPAN BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD BILLION)
• TABLE 82. JAPAN BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
• TABLE 83. MALAYSIA BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
• TABLE 84. MALAYSIA BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD BILLION)
• TABLE 85. MALAYSIA BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
• TABLE 86. PHILIPPINES BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
• TABLE 87. PHILIPPINES BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD BILLION)
• TABLE 88. PHILIPPINES BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
• TABLE 89. SINGAPORE BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
• TABLE 90. SINGAPORE BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD BILLION)
• TABLE 91. SINGAPORE BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
• TABLE 92. SOUTH KOREA BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
• TABLE 93. SOUTH KOREA BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD BILLION)
• TABLE 94. SOUTH KOREA BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
• TABLE 95. TAIWAN BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
• TABLE 96. TAIWAN BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD BILLION)
• TABLE 97. TAIWAN BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
• TABLE 98. THAILAND BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
• TABLE 99. THAILAND BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD BILLION)
• TABLE 100. THAILAND BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
• TABLE 101. VIETNAM BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
• TABLE 102. VIETNAM BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD BILLION)
• TABLE 103. VIETNAM BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
• TABLE 104. EUROPE, MIDDLE EAST & AFRICA BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
• TABLE 105. EUROPE, MIDDLE EAST & AFRICA BIOTECHNOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD BILLION)
• TABLE 106. EUROPE, MIDDLE EAST & AFRICA BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD BILLION)
• TABLE 107. EUROPE, MIDDLE EAST & AFRICA BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
• TABLE 108. DENMARK BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
• TABLE 109. DENMARK BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD BILLION)
• TABLE 110. DENMARK BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
• TABLE 111. EGYPT BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
• TABLE 112. EGYPT BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD BILLION)
• TABLE 113. EGYPT BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
• TABLE 114. FINLAND BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
• TABLE 115. FINLAND BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD BILLION)
• TABLE 116. FINLAND BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
• TABLE 117. FRANCE BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
• TABLE 118. FRANCE BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD BILLION)
• TABLE 119. FRANCE BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
• TABLE 120. GERMANY BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
• TABLE 121. GERMANY BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD BILLION)
• TABLE 122. GERMANY BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
• TABLE 123. ISRAEL BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
• TABLE 124. ISRAEL BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD BILLION)
• TABLE 125. ISRAEL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
• TABLE 126. ITALY BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
• TABLE 127. ITALY BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD BILLION)
• TABLE 128. ITALY BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
• TABLE 129. NETHERLANDS BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
• TABLE 130. NETHERLANDS BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD BILLION)
• TABLE 131. NETHERLANDS BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
• TABLE 132. NIGERIA BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
• TABLE 133. NIGERIA BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD BILLION)
• TABLE 134. NIGERIA BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
• TABLE 135. NORWAY BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
• TABLE 136. NORWAY BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD BILLION)
• TABLE 137. NORWAY BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
• TABLE 138. POLAND BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
• TABLE 139. POLAND BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD BILLION)
• TABLE 140. POLAND BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
• TABLE 141. QATAR BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
• TABLE 142. QATAR BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD BILLION)
• TABLE 143. QATAR BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
• TABLE 144. RUSSIA BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
• TABLE 145. RUSSIA BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD BILLION)
• TABLE 146. RUSSIA BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
• TABLE 147. SAUDI ARABIA BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
• TABLE 148. SAUDI ARABIA BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD BILLION)
• TABLE 149. SAUDI ARABIA BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
• TABLE 150. SOUTH AFRICA BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
• TABLE 151. SOUTH AFRICA BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD BILLION)
• TABLE 152. SOUTH AFRICA BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
• TABLE 153. SPAIN BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
• TABLE 154. SPAIN BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD BILLION)
• TABLE 155. SPAIN BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
• TABLE 156. SWEDEN BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
• TABLE 157. SWEDEN BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD BILLION)
• TABLE 158. SWEDEN BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
• TABLE 159. SWITZERLAND BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
• TABLE 160. SWITZERLAND BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD BILLION)
• TABLE 161. SWITZERLAND BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
• TABLE 162. TURKEY BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
• TABLE 163. TURKEY BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD BILLION)
• TABLE 164. TURKEY BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
• TABLE 165. UNITED ARAB EMIRATES BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
• TABLE 166. UNITED ARAB EMIRATES BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD BILLION)
• TABLE 167. UNITED ARAB EMIRATES BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
• TABLE 168. UNITED KINGDOM BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD BILLION)
• TABLE 169. UNITED KINGDOM BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD BILLION)
• TABLE 170. UNITED KINGDOM BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
• TABLE 171. GLOBAL BIOTECHNOLOGY MARKET: FPNV POSITIONING MATRIX - SCORES, 2022
• TABLE 172. GLOBAL BIOTECHNOLOGY MARKET: FPNV POSITIONING MATRIX - BUSINESS STRATEGY, 2022
• TABLE 173. GLOBAL BIOTECHNOLOGY MARKET: FPNV POSITIONING MATRIX - PRODUCT SATISFACTION, 2022
• TABLE 174. GLOBAL BIOTECHNOLOGY MARKET RANKING, BY KEY PLAYER, 2022
• TABLE 175. GLOBAL BIOTECHNOLOGY MARKET SHARE, BY KEY PLAYER, 2022
• TABLE 176. GLOBAL BIOTECHNOLOGY MARKET PRODUCT PORTFOLIO ANALYSIS, BY KEY PLAYER, 2022
• TABLE 177. GLOBAL BIOTECHNOLOGY MARKET MERGER & ACQUISITION
• TABLE 178. GLOBAL BIOTECHNOLOGY MARKET AGREEMENT, COLLABORATION, & PARTNERSHIP
• TABLE 179. GLOBAL BIOTECHNOLOGY MARKET NEW PRODUCT LAUNCH & ENHANCEMENT
• TABLE 180. GLOBAL BIOTECHNOLOGY MARKET INVESTMENT & FUNDING
• TABLE 181. GLOBAL BIOTECHNOLOGY MARKET AWARD, RECOGNITION, & EXPANSION
• TABLE 182. GLOBAL BIOTECHNOLOGY MARKET: LICENSE & PRICING

The Global Biotechnology Market size was estimated at USD 1,023.15 billion in 2022 and expected to reach USD 1,195.30 billion in 2023, projecting growth at a CAGR of 16.96% to reach USD 3,583.36 billion by 2030.

Cumulative Impact of COVID-19:

COVID-19 is an unprecedented global public health emergency that affected almost every industry, and the long-term impacts are projected to reflect on the growth of various end-use industries during the forecast period. This ongoing research amplifies the research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19, considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The dedicated section in the report uncovers a detailed analysis of the impact of COVID-19 and its subsequent variant outbreaks on demand, supply, price, and vendor uptake and provides recommendations for sustainable outcomes. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the Global Biotechnology Market.

Cumulative Impact of Russia-Ukraine Conflict:

We continuously monitor and update reports considering unceasing political and economic uncertainty due to the Russia-Ukraine Conflict. Negative impacts are globally foreseen, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected people's lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on Ukraine and reverberate harsh long-term effects on Russia. The report uncovers the implications for demand-supply balances, pressure on pricing variants, impact on import/export and trading, and short-term recommendations to the Global Biotechnology Market considering the current update on the conflict and its global responses.

Cumulative Impact of High Inflation:

The high inflation in developed economies globally has resulted in an overall price surge over the past two years. The cumulatively eroding overall purchasing power is expected to impact developing economies significantly and is considered helpful in numerous ways. The report uncovers the effect of high inflation on the long-term performance of the global economy and provides details on fiscal policies measuring and reducing its short-term impacts on demand/supply, cash flow, and currency exchange. The Global Biotechnology Market report delivers the high inflation expectation considering the related impact from cost-push and demand-pull inflation.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make better decisions. In this report, the years 2018 and 2021 are considered as historical years, 2022 as the base year, 2023 as the estimated year, and years from 2024 to 2030 are considered as the forecast period.

Market Segmentation & Coverage:

The report on the Global Biotechnology Market identifies key attributes about the customer to define the potential market and identify different needs across the industry. Understanding the potential customer group's economies and geographies can help gain business acumen for better strategic decision-making. Our market coverage across different industry verticals reveals the hidden truth about the players' strategies in different verticals and helps the organization decide target audience. This report gives you the composite view of sub-markets coupled with comprehensive industry coverage and provides you with the right way of accounting factors such as norms & regulations, culture, to make right coverage strategy for your market plan. This research report categorizes the Global Biotechnology Market in order to forecast the revenues and analyze the trends in each of the following sub-markets.

Based on Technology, the market is studied across Cell-Based Assays, Chromatography, DNA Sequencing, Fermentation, Nanobiotechnology, PCR Technology, and Tissue Engineering & Regeneration.

Based on Application, the market is studied across Bioinformatics, Food & Agriculture, Health, Industrial Processing, and Natural Resources & Environment.

Based on Region, the market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes vendors in the Global Biotechnology Market. based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) and placed into four quadrants (F: Forefront, P: Pathfinder, N: Niche, and V: Vital). The Global Biotechnology Market FPNV Positioning Matrix representation/visualization further aids businesses in better decision-making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market, providing the idea of revenue generation into the overall market compared to other vendors in the space. This provides insights on vendors performance in terms of revenue generation and customer base compared to others. The Global Biotechnology Market Share Analysis offers an idea of the size and competitiveness of the vendors for the base year. The outcome reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:

The Competitive Scenario provides an outlook analysis of the various strategies for business growth adopted by the vendors. The news in this section covers valuable insights at various stages while keeping up with the business and engaging stakeholders in the economic debate. The Global Biotechnology Market Competitive Scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected helps vendors understand the gaps in the marketplace and competitor's strengths and weaknesses, providing insights to enhance products and services.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Biotechnology Market, including Abbott Laboratories Ltd., Agilent Technologies, Inc., Amgen Inc., Bio-Rad Laboratories, Inc., bioMerieux SA, Danaher Corporation, F. Hoffmann-La Roche AG, General Electric Company, Gilead Sciences, Inc., Lonza Group, Novartis AG, Novo Nordisk A/S, PerkinElmer, Inc., QIAGEN, Samudra Biopharma Pvt. Ltd, and Thermo Fisher Scientific Inc.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Biotechnology Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Biotechnology Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Biotechnology Market?

4. What is the competitive strategic window for opportunities in the Global Biotechnology Market?

5. What are the technology trends and regulatory frameworks in the Global Biotechnology Market?

6. What is the market share of the leading vendors in the Global Biotechnology Market?

7. What modes and strategic moves are considered suitable for entering the Global Biotechnology Market?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Limitations
• 1.7. Assumptions
• 1.8. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rising interest for sustenance and horticultural items
    • 5.1.1.2. Growing incidence of persistent health conditions
    • 5.1.1.3. Surging demand for personalized medicines coupled with the early detection of diseases
  • 5.1.2. Restraints
    • 5.1.2.1. Risk associated to genetic data
  • 5.1.3. Opportunities
    • 5.1.3.1. Emergence of innovative technologies
    • 5.1.3.2. Escalating demand for agriculture-based products
  • 5.1.4. Challenges
    • 5.1.4.1. Adverse environmental impact due to biotechnology
• 5.2. Cumulative Impact of COVID-19
• 5.3. Cumulative Impact of Russia-Ukraine Conflict
• 5.4. Cumulative Impact of High Inflation
• 5.5. Porter's Five Forces Analysis
  • 5.5.1. Threat of New Entrants
  • 5.5.2. Threat of Substitutes
  • 5.5.3. Threat of Substitutes
  • 5.5.4. Threat of Substitutes
  • 5.5.5. Industry Rivalry
• 5.6. Value Chain & Critical Path Analysis
• 5.7. Regulatory Framework
• 5.8. Client Customization

6. Biotechnology Market, by Technology

• 6.1. Introduction
• 6.2. Cell-Based Assays
• 6.3. Chromatography
• 6.4. DNA Sequencing
• 6.5. Fermentation
• 6.6. Nanobiotechnology
• 6.7. PCR Technology
• 6.8. Tissue Engineering & Regeneration

7. Biotechnology Market, by Application

• 7.1. Introduction
• 7.2. Bioinformatics
• 7.3. Food & Agriculture
• 7.4. Health
• 7.5. Industrial Processing
• 7.6. Natural Resources & Environment

8. Americas Biotechnology Market

• 8.1. Introduction
• 8.2. Argentina
• 8.3. Brazil
• 8.4. Canada
• 8.5. Mexico
• 8.6. United States

9. Asia-Pacific Biotechnology Market

• 9.1. Introduction
• 9.2. Australia
• 9.3. China
• 9.4. India
• 9.5. Indonesia
• 9.6. Japan
• 9.7. Malaysia
• 9.8. Philippines
• 9.9. Singapore
• 9.10. South Korea
• 9.11. Taiwan
• 9.12. Thailand
• 9.13. Vietnam

10. Europe, Middle East & Africa Biotechnology Market

• 10.1. Introduction
• 10.2. Denmark
• 10.3. Egypt
• 10.4. Finland
• 10.5. France
• 10.6. Germany
• 10.7. Israel
• 10.8. Italy
• 10.9. Netherlands
• 10.10. Nigeria
• 10.11. Norway
• 10.12. Poland
• 10.13. Qatar
• 10.14. Russia
• 10.15. Saudi Arabia
• 10.16. South Africa
• 10.17. Spain
• 10.18. Sweden
• 10.19. Switzerland
• 10.20. Turkey
• 10.21. United Arab Emirates
• 10.22. United Kingdom

11. Competitive Landscape

• 11.1. FPNV Positioning Matrix
  • 11.1.1. Quadrants
  • 11.1.2. Business Strategy
  • 11.1.3. Product Satisfaction
• 11.2. Market Ranking Analysis, By Key Player
• 11.3. Market Share Analysis, By Key Player
• 11.4. Product Portfolio Analysis, By Key Player
• 11.5. Competitive Scenario
  • 11.5.1. Merger & Acquisition
  • 11.5.2. Agreement, Collaboration, & Partnership
  • 11.5.3. New Product Launch & Enhancement
  • 11.5.4. Investment & Funding
  • 11.5.5. Award, Recognition, & Expansion

12. Company Usability Profiles

• 12.1. Abbott Laboratories Ltd.
• 12.2. Agilent Technologies, Inc.
• 12.3. Amgen Inc.
• 12.4. Bio-Rad Laboratories, Inc.
• 12.5. bioMerieux SA
• 12.6. Danaher Corporation
• 12.7. F. Hoffmann-La Roche AG
• 12.8. General Electric Company
• 12.9. Gilead Sciences, Inc.
• 12.10. Lonza Group
• 12.11. Novartis AG
• 12.12. Novo Nordisk A/S
• 12.13. PerkinElmer, Inc.
• 12.14. QIAGEN
• 12.15. Samudra Biopharma Pvt. Ltd
• 12.16. Thermo Fisher Scientific Inc

13. Appendix

• 13.1. Discussion Guide
• 13.2. License & Pricing